Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1α by interferon-β

Journal of Neuroimmunology

Volumn 112, Issue 1-2, 2001, Pages 174-180

  Zang, Ying C Q ^a   Halder, Jyotsnabaran B ^a   Samanta, Ajoy K ^a   Hong, Jian ^a   Rivera, Victor M ^a   Zhang, Jingwu Z ^a,b  

^a Baylor Methodist Multiple Sclerosis Center   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CCR5; Chemokines; Cytokines; Interferon ; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; CELL SURFACE RECEPTOR; CHEMOKINE RECEPTOR CCR5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE MIGRATION; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE;

ADULT; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON-BETA; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; RANTES; RECEPTORS, CCR5; RNA, MESSENGER; T-LYMPHOCYTES;

EID: 0035212393     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00397-0     Document Type: Article

References (31)

1. Mechanisms of action of interferon-β in multiple sclerosis
2. CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-and IP-10 are expressed in demyelination brain lesions
3. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
4. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
5. RANTES, IFN-γ, CCR1, and CCR5 mRNA expression in peripheral blood, lymph node, and bronchoalveolar lavage mononuclear cells during primary simian immunodeficiency virus infection of macaques
6. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
7. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
8. Immune-mediated demyelination
9. Circulating adhesion molecules and tumor necrosis factor receptor in multiple sclerosis: Correlation with magnetic resonance imaging
10. Increased levels in vivo of mRNAs for IL-8 and macrophage inflammatory protein-1 α (MIP-1 α), but not of RANTES mRNA in peripheral blood mononuclear cells of patients with atopic dermatitis (AD)
11. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals
12. A common T cell receptor V-D-J sequence in Vb13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis
13. Perivascular T cells express the proinflammatory chemokine RANTES mRNA in multiple sclerosis lesions
14. Intramuscular interferon β-1a for disease progression in relapsing multiple sclerosis
15. Interferon β induces Th2 immune deviation in MS
16. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Score (EDSS)
17. Interferon-β 1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis
18. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes
19. An improved in vitro assay to quantitate chemotaxis of rat peripheral blood large granular lymphocytes (LGL)
20. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
21. Interferon-β induces interleukin-10 expression: Relevance to multiple sclerosis
22. In vivo effects of interferon β-1a on immunosuppressive cytokines in multiple sclerosis
23. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
24. Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions
25. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients
26. Chemotaxis of T lymphocytes on extracellular matrix proteins
27. Interferon β-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double blind, placebo-controlled trial
28. Aberrant T cell migration toward RANTES and MIP-1α in patients with multiple sclerosis: Over-expression of chemokine receptor CCR5
29. Myelin basic protein-specific T lymphocytes in multiple sclerosis and controls: Precursor frequency, fine specificity, and cytotoxicity
30. The chemokine receptor CCR8 is preferentially expressed in Th2 but not in Th1 cells